Skip to content

The effectiveness of microfocused ultrasound for treatment of hyperhidrosis of axilla

The effectiveness of microfocused ultrasound for treatment of hyperhidrosis of axilla

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250317006
Enrollment
21
Registered
2025-03-17
Start date
2024-12-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperhidrosis hyperhidrosis , microfocused ultrasound ,hyperhidrosis severity scale ,Tewameter

Interventions

Microfocused ultrasound 1.5 jcm2
Experimental Device

Sponsors

Doctor Chin Clinic
Lead Sponsor
Doctor Chin Clinic
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 20-55 years, regardless of gender. If female, must not be in menopause. 2. Diagnosed with axillary hyperhidrosis with a Hyperhidrosis Severity Scale score greater than 2. 3. Must not have any of the following conditions: diabetes, hyperthyroidism, hyperpituitarism, lymphoma, or any endocrine disorders that cause excessive sweating. 4. Must not have any neurological disorders that cause excessive sweating. 5. Must not be taking any of the following medications: opioids, ganglionic blockers, anticholinergics, or carbonic anhydrase inhibitors. 6. Must not be allergic to iodine. 7. Must not have undergone treatment with microfocused ultrasound in the axillary area or any other sweat-reducing procedures within 6 months prior to participation in the study. 8. Must not have received botulinum toxin (Botox) injections in the axillary area within 12 months prior to participation in the study. 9. Must not be pregnant or breastfeeding.

Exclusion criteria

Exclusion criteria: 1. The volunteer withdraws from the study. 2. The volunteer experiences severe side effects from the experiment during the study. 3. The volunteer does not comply with the research requirements. 4. The volunteer changes their use of medication or other antiperspirant agents. 5. The volunteer undergoes a procedure or surgery that alters the skin or affects sweat secretion. 6. The volunteer takes medication that influences sweat secretion. 7. The volunteer develops a medical condition during the study that impacts the research.

Design outcomes

Primary

MeasureTime frame
hyperhidrosis 3 months Tewameter

Secondary

MeasureTime frame
Hyperhidrosis Severity Scale score 3 months Patient reported outcome using a questionnaire interview

Countries

Thailand

Contacts

Public ContactRattaphum Kansaksiri

Doctor Chin Clinic

rattaphum.ks@gmail.com0994939895

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026